Biopharmaceutical firm AstraZeneca on Thursday said it has expanded its global hub in Bengaluru with an investment of Rs166 ...

When Pascal Soriot flew in to speak at the Boao Forum in China this year, many expected him to keep a low profile. With ...

The drug was approved to treat patients who have already received chemotherapy under an accelerated approval process after a ...

Global bio-pharmaceutical company AstraZeneca has established its state-of-the-art Global Hub in Bengaluru investing Rs 166 ...

Bengaluru: Global biopharmaceutical company AstraZeneca is investing Rs166 crore to expand its Bengaluru operations, creating ...

AstraZeneca has launched a new Global Hub in Bengaluru, investing Rs 166 crore for AI healthcare solutions. This move aims to ...

AstraZeneca and its partner Daiichi Sankyo have won approval from U.S. regulators for their precision drug Datroway to treat ...

Cambridge: AstraZeneca has announced that Datroway (datopotamab deruxtecan or Dato-DXd) has received accelerated approval ...

This was the ADR's second consecutive day of losses.

AstraZeneca has started the process to improve its cancer treatment capabilities with an addition to its campus in southwest ...

AstraZeneca invests Rs 166 crore in a new Bengaluru Global Hub focused on AI-driven healthcare solutions, creating 400 new ...

The findings come from the global, multicenter, open-label, and single-arm Phase I/II SYRUS clinical trial (NCT06137118), ...